Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Cefepime Dihydrochloride. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN105859747A reveals a low-cost anhydrous refining process for high-purity Cefepime, ensuring supply chain stability and reduced manufacturing expenses.
Patent CN1140714A details a stable crystalline cis-isomer intermediate for cefepime production, offering improved purity and simplified aqueous acylation processes for pharmaceutical manufacturers.
Patent CN1070398A details anhydrous acylation for Cefepime. Reduces isomers, improves stability, lowers manufacturing costs for global supply chains.